News

Although Implanon has maintained its “approvable” status, Organon will meet with the agency over the next few weeks to discuss any outstanding issues. Organon is said to be

This double-blind, randomized, placebo-controlled study will evaluate the tolerability, safety and antiviral activity of GS 9137 (also known as JTK-303), in HIV-positive patients. The drug will be administered

The double-blinded clinical study compared recombinant human hyaluronidase (rHuPH20) to a saline control in 100 healthy human volunteers. These volunteers were injected intradermally with rHuPH20 in one forearm

The company plans to begin a phase III study in recurrent respiratory papillomatosis (RRP) in the first quarter of 2006, pending review by the FDA. The study will

The company succeeded in achieving the primary endpoint of the trial to establish the safety of the drug. BrachySil (32-P BioSilicon) was found to be both safe and

The follow-up data from the Teva’s four year trial showed the drug’s efficacy compared with beta interferon therapies. Final results of a four year study using a prospectively

The drug was evaluated in a TNBS-induced ulcerative colitis mouse model, which is an animal model widely used to evaluate drug candidates for treatment of human inflammatory bowel

The multi-center study has enrolled over 600 women diagnosed with irritable bowel syndrome (IBS). This US investigation is designed to compare the safety and efficacy of PTI-901 against

The technology results in an unprecedented control over the shape, size and composition of material. The particles produced are made from bioabsorbable organic materials creating a nontoxic method